Assays for hepatitis B surface antigen (HBsAg) are the most frequently used tests to detect HBV infection. Vaccination for HBV can produce transiently detectable levels of HBsAg in patients.

However, in clinical practice, hepatitis B e antigen (HBeAg)-negative CHB is frequently arbitrarily referred to as precore mutant CHB, although the 2 terms are not synonymous. Because no ...

Ed Arce, an analyst from H.C. Wainwright, maintained the Buy rating on Arbutus Biopharma (ABUS – Research Report). The associated price ...

upon chart review of 768 pregnant patients seeking prenatal care at the outpatient clinic from January to July 2014, the ...

bepirovirsen at a dose of 300 mg per week over 24 weeks resulted in sustained hepatitis B surface antigen (HBsAg) and HBV DNA loss to below the limits of detection in 9% to 10% of participants ...

Interim results from the phase 2b B-Clear showed that bepirovirsen reduced levels of hepatitis B surface antigen (HBsAg) and HBV DNA after 24 weeks' treatment to below the lower limit of detection ...

The global hepatitis B diagnostic tests market is on the cusp of substantial expansion, driven by a combination of increasing disease incidence, heightened global awareness campaigns, and rapid ...

Jefferies London Healthcare Conference: Fireside Chat on November 21, 2024 at 12:00 pm GMT / 7:00 am EST To access the live webcast of the fireside chat, please visit: ...

Strong public health support and creating an open environment that enables MSM to follow recommendations will be crucial to ...

About BJT-778 BJT-778 is a high-potency, fully human immunoglobulin G1 (IgG1) monoclonal antibody (mAb) specifically against hepatitis B surface antigen (anti-HBsAg mAb). BJT-778 neutralizes and ...